Aerie Pharmaceuticals announces U.S. FDA approval of Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% for the reduction of intra-ocular pressure in patients with open-angle glaucoma or ocular hypertension

12 March 2019 - Aerie Pharmaceuticals today announced that the U.S. FDA has approved Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% ...

Read more →

Vertex receives approval for Symdeko (tezacaftor/ivacaftor and ivacaftor) in Australia, to treat the underlying cause of cystic fibrosis in people aged 12 and older with certain CFTR gene mutations

12 March 2019 - A new treatment option for patients with two copies of the F508del mutation, the most common mutation ...

Read more →

Cystic fibrosis breakthrough: vital drug could be made available as early as next month

8 March 2019 - A wonder drug that could dramatically improve the lives of thousands of cystic fibrosis patients may be ...

Read more →

Campaigners call for NHS access to Orkambi as MP inquiry gets underway

8 March 2019 - Patients and campaigners took to the streets in London yesterday demanding NHS access to Vertex’ cystic ...

Read more →

High price of cystic fibrosis drug not political, firm's boss tells MPs

8 March 2019 - CEO of company that makes Orkambi denies being ‘political minion’ for Donald Trump. ...

Read more →

How to fix a problem like Orkambi? Solutions suggested ahead of showdown

5 March 2019 - Approaches used in France and Germany could help break deadlock. ...

Read more →

Vertex chief Jeffrey Leiden to weigh in on Orkambi inquiry

4 March 2019 - Vertex’s long-running spat with NHS England has amounted to a legal inquiry scheduled to begin this Thursday, ...

Read more →

New HIV drug gets cheaper with subsidies

1 March 2019 - Australians living with HIV will soon have another treatment drug available to them at a more ...

Read more →

Esperion announces submissions of two NDAs and official completion of two MAA validations for both bempedoic acid and the bempedoic acid/ezetimibe combination tablet

28 February 2019 - Esperion today announced that the company has successfully completed important and key global marketing applications including ...

Read more →

FDA approves Taiho Oncology's Lonsulf (trifluridine/tipiracil) for adult patients with previously treated advanced gastric or gastro-esophageal junction (GEJ) Adenocarcinoma

25 February 2019 - Taiho Oncology today announced that the United States FDA has approved Lonsulf as a treatment for adult ...

Read more →

Bausch Health provides update for Duobrii filing

15 February 2019 - Bausch Health announced that the U.S. FDA will be unable to meet today's Prescription Drug User Fee ...

Read more →

Cystic fibrosis breakthrough: hope for British sufferers as life-saving drug talks resume

14 February 2019 - Britain's cystic fibrosis sufferers have received fresh hope of receiving a life-saving drug after officials agreed to ...

Read more →

New weight loss pill launched in Australia

14 February 2019 - A new medication to help fight obesity has been launched in Australia. ...

Read more →

Vertex fears its triplet will also face UK reimbursement battle

6 February 2019 - Vertex Pharmaceuticals' cystic fibrosis business grew more than 40% in 2018, partially because of reimbursement victories in ...

Read more →

UK patient activist group takes aim at Orkambi patent

4 February 2019 - Calls to bypass patent adds to pressure on Vertex. ...

Read more →